Advances in mRNA Vaccines for Infectious Diseases

During the last two decades, there has been broad interest in RNA-based technologies for the development of prophylactic and therapeutic vaccines. Preclinical and clinical trials have shown that mRNA vaccines provide a safe and long-lasting immune response in animal models and humans. In this review, we summarize current research progress on mRNA vaccines, which have the potential to be quick-manufactured and to become powerful tools against infectious disease and we highlight the bright future of their design and applications.

• Publication year

  2019

• Venue

  Frontiers in Immunology

• Publication date

  2019-03-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fimmu.2019.00594PMID 30972078PMCID 6446947
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening.

  2019cited by this paper
• Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation.

  2019cited by this paper
• Maximizing the Translational Yield of mRNA Therapeutics by Minimizing 5′-UTRs

  2019cited by this paper
• DNA and mRNA vaccination against allergies

  2018cited by this paper
• Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

  2018cited by this paper
• Safety Evaluation of Lipid Nanoparticle–Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey

  2018cited by this paper
• An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections

  2018cited by this paper
• Proximity Ligation Assays for In Situ Detection of Innate Immune Activation: Focus on In Vitro-Transcribed mRNA

  2018cited by this paper
• Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA

  2018cited by this paper
• mRNA vaccines — a new era in vaccinology

  2018influential reference
• Extracellular RNA Sensing by Pattern Recognition Receptors

  2018cited by this paper
• Biomaterials for vaccine‐based cancer immunotherapy

  2018cited by this paper
• Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease

  2018cited by this paper
• Scaffold-mediated delivery for non-viral mRNA vaccines

  2018cited by this paper
• Immunocastration of goats using anti-gonadotrophin releasing hormone vaccine.

  2018cited by this paper
• New Vaccine Technologies to Combat Outbreak Situations

  2018cited by this paper
• mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice

  2018cited by this paper
• Going Fishing

  2018cited by this paper
• New Kids on the Block: RNA-Based Influenza Virus Vaccines

  2018cited by this paper
• &egr;‐Poly‐L‐Lysine/plasmid DNA nanoplexes for efficient gene delivery in vivo

  2018cited by this paper
• Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

  2018cited by this paper
• mRNA Delivery System for Targeting Antigen‐Presenting Cells In Vivo

  2018cited by this paper
• Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters

  2018cited by this paper
• Design of Polymeric Gene Carriers for Effective Intracellular Delivery.

  2018cited by this paper
• Latest development on RNA-based drugs and vaccines

  2018cited by this paper
• Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice

  2018cited by this paper
• Microneedle Patches as Drug and Vaccine Delivery Platform.

  2017cited by this paper
• Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design

  2017cited by this paper
• Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

  2017cited by this paper
• Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens.

  2017cited by this paper
• Type I Interferons Modulate CD8+ T Cell Immunity to mRNA Vaccines.

  2017cited by this paper
• Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines

  2017cited by this paper
• Zika virus protection by a single low dose nucleoside modified mRNA vaccination

  2017cited by this paper
• RIG-I-Like Receptors and Type I Interferonopathies

  2017cited by this paper
• Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains

  2017cited by this paper
• A thermostable messenger RNA based vaccine against rabies

  2017cited by this paper
• Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.

  2017cited by this paper
• A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine

  2017cited by this paper
• A successful founder off the beaten path

  2017cited by this paper
• Preventive therapy for cancer.

  2017cited by this paper
• Mechanism of action of mRNA-based vaccines

  2017cited by this paper
• Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge

  2017cited by this paper
• On message.

  2017cited by this paper
• Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells

  2017cited by this paper
• The 'anti-hype' vaccine

  2017cited by this paper
• Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses

  2017cited by this paper
• Modified mRNA Vaccines Protect against Zika Virus Infection.

  2017cited by this paper
• Nucleoside Modified mRNA Vaccines for Infectious Diseases.

  2017cited by this paper
• Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems

  2017cited by this paper
• Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.

  2017cited by this paper
• mRNA Cancer Vaccines-Messages that Prevail.

  2017cited by this paper
• Recent innovations in mRNA vaccines.

  2016cited by this paper
• mRNA Cancer Vaccines.

  2016cited by this paper
• Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus

  2016cited by this paper
• Materials for non-viral intracellular delivery of messenger RNA therapeutics.

  2016cited by this paper
• Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge

  2016cited by this paper
• Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose

  2016cited by this paper
• Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways.

  2016cited by this paper
• Self-Replicating RNA

  2016cited by this paper
• Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon

  2016cited by this paper
• Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial

  2016cited by this paper
• An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs

  2016cited by this paper
• mRNA capping: biological functions and applications

  2016cited by this paper
• Replicon RNA Viral Vectors as Vaccines

  2016cited by this paper
• Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity.

  2016cited by this paper
• Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines.

  2016cited by this paper
• Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

  2016cited by this paper
• Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA

  2016cited by this paper
• mRNA vaccine delivery using lipid nanoparticles.

  2016cited by this paper
• Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and Interferon Induction

  2015cited by this paper
• Self-replicating alphavirus RNA vaccines

  2015cited by this paper
• Dissociation of skeletal muscle for flow cytometric characterization of immune cells in macaques.

  2015cited by this paper
• Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin

  2015cited by this paper
• Regulation of antiviral T cell responses by type I interferons

  2015cited by this paper
• Japanese encephalitis virus replicon-based vaccine expressing enterovirus-71 epitope confers dual protection from lethal challenges

  2015cited by this paper
• Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals

  2015cited by this paper
• Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7

  2015cited by this paper
• Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.

  2015cited by this paper
• Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO system

  2015cited by this paper
• A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates.

  2015cited by this paper
• N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice.

  2015cited by this paper
• Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

  2015cited by this paper
• mRNA transcript therapy

  2015cited by this paper
• Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells

  2015cited by this paper
• Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I

  2015cited by this paper
• Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.

  2015cited by this paper
• Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates

  2014cited by this paper
• Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

  2014cited by this paper
• Induction of Cytomegalovirus-Specific T Cell Responses in Healthy Volunteers and Allogeneic Stem Cell Recipients Using Vaccination With Messenger RNA–Transfected Dendritic Cells

  2014cited by this paper
• Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen.

  2014cited by this paper
• A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs

  2014cited by this paper
• mRNA-based therapeutics — developing a new class of drugs

  2014cited by this paper
• T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.

  2014cited by this paper
• Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines

  2014cited by this paper
• Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses.

  2014cited by this paper
• A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model.

  2014cited by this paper
• A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

  2014cited by this paper
• The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination

  2014cited by this paper
• In vitro synthesis of modified mRNA for induction of protein expression in human cells.

  2014cited by this paper
• Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo

  2014cited by this paper

• Cracking the Capsid Code: A Computationally-Feasible Approach for Investigating Virus-Excipient Interactions in Biologics Design

  2026cites this paper
• The Stealth Hazard: Tungsten in Prefilled Syringes Induces mRNA Degradation and Functional Loss in Lipid Nanoparticles Despite Apparent Biophysical Stability.

  2026cites this paper
• High-sensitivity multilayer SPR biosensor based on ZnO/Graphene/Ag/MXene architecture for simultaneous detection of leptospirosis, malaria, and glucose imbalance

  2026cites this paper
• Identification of Phage RNA Polymerases That Minimize Double-Stranded RNA By-Product Formation and Their Characterization via In Vitro Transcription

  2026cites this paper
• Recent approaches of proliposome-based dry powder inhalation for pulmonary delivery

  2026cites this paper
• Comprehensive characterization of multivalent mRNA vaccines functionality by flow cytometry and mass spectrometry.

  2026cites this paper
• Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches.

  2026cites this paper
• One health perspectives on the epidemiological features and changing incidence of natural focus and vector-borne infectious diseases in China: An observational trend study

  2026cites this paper
• mRNA Technology Beyond Vaccines: Exploring Potential mRNA-Based Therapies for Autoimmune Diseases

  2026cites this paper
• MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNA

  2025cites this paper
• Intramuscular delivery of mRNA-encoded single-chain variable fragments prevents myotoxin II-induced skeletal muscle damage in a preclinical model.

  2025cites this paper
• Lipid nanoparticle-delivered mRNA vaccine encoding the MOMP of Chlamydia psittaci elicits protective immune responses in BALB/c mice

  2025cites this paper
• An mRNA vaccine encoding multiple envelope glycoproteins of porcine reproductive and respiratory syndrome virus confers efficient protection against NADC30-like strains.

  2025cites this paper
• Development of a multi-epitope mRNA vaccine candidate for oropouche virus: an in-silico approach for immune response optimization and molecular stability

  2025cites this paper
• Combination of ionizable lipids with oleic acid and vitamin E scaffolds for RNA cancer vaccine delivery.

  2025cites this paper
• Livestock Antibiotics Use and Antimicrobial Resistance

  2025cites this paper
• Advances in the Functionalization of Vaccine Delivery Systems: Innovative Strategies and Translational Perspectives

  2025cites this paper
• Harnessing the Loop: The Perspective of Circular RNA in Modern Therapeutics

  2025cites this paper
• A Systematic Review of Clinical Trials Using mRNA Vaccines for Infectious Diseases other than COVID-19

  2025cites this paper
• Comprehensive epidemiological study on COVID-19: Characteristics, diagnosis, and therapeutic approaches

  2025cites this paper
• Efficient Delivery of SARS-CoV-2 Plasmid DNA in HEK-293T Cells Using Chitosan Nanoparticles

  2025cites this paper
• COVID-19 Vaccines Development: Challenges and Future Perspective

  2025cites this paper
• Neutralizing antibodies induced by IpaB and IpaC mRNA vaccines inhibit Shigella flexneri invasion

  2025cites this paper
• Acquired immunity mechanisms in sheep infected with Nematodirus oiratianus: key genes and host responses

  2025cites this paper
• To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization

  2025cites this paper
• Next‐Generation Vaccines for Co‐Circulating PEDV and TGEV: Integrating Nucleic Acid Platforms, Mucosal Delivery, and AI–Driven Antigen Design

  2025cites this paper
• An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease

  2025cites this paper
• Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups - The CONVERS project, report from a pediatric tertiary hospital.

  2025cites this paper
• Emerging Frontiers in Colorectal Cancer Therapy: From Targeted Molecules to Immunomodulatory Breakthroughs and Cell-Based Approaches

  2025cites this paper
• Decrypting the Immune Symphony for RNA Vaccines

  2025cites this paper
• Harnessing immunopeptidomics for next-generation vaccines against intracellular bacterial pathogens

  2025cites this paper
• Natural killer cell therapy in hepatocellular carcinoma: a comprehensive review

  2025cites this paper
• RNA therapeutics—An evaluation of potential occupational health hazards and a strategy to establish occupational exposure limits (OELs)

  2025cites this paper
• Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review

  2025cites this paper
• Spike protein-related proteinopathies: a focus on the neurological side of spikeopathies.

  2025cites this paper
• Innate Sensing of Viral Nucleic Acids and Their Use in Antiviral Vaccine Development

  2025cites this paper
• Multiscale dynamic immunomodulation by a nanoemulsified Trojan-TLR7/8 adjuvant for robust protection against heterologous pandemic and endemic viruses

  2025cites this paper
• Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods

  2025cites this paper
• Advances in Virus Biorecognition and Detection Techniques for the Surveillance and Prevention of Infectious Diseases

  2025cites this paper
• mRNA vaccines for prostate cancer: A novel promising immunotherapy.

  2025cites this paper
• mRNA-LM: full-length integrated SLM for mRNA analysis

  2025cites this paper
• An LNP-mRNA vaccine protects fish against rhabdovirus infection.

  2025cites this paper
• Recent strategies for enhanced delivery of mRNA to the lungs.

  2025cites this paper
• Removal of dsRNA byproducts using affinity chromatography

  2025cites this paper
• DNA and mRNA vaccines: Significant therapeutic approach against cancer management.

  2025cites this paper
• Nanomaterial Applications in Prevention and Treatment Strategies of Virus: A Review.

  2025cites this paper
• Tailoring Lipid Nanoparticle with Ex Situ Incorporated Conjugated Oligoelectrolyte for Enhanced mRNA Delivery Efficiency

  2025cites this paper
• Needle-Free Jet-Delivered mRNA-Vaccine Encoding Influenza A(H1N1)pdm09 Hemagglutinin Protects Mice from Lethal Virus Infection

  2025cites this paper
• Enhancing Antitumor Efficacy of MUC1 mRNA Nano-Vaccine by CTLA-4 siRNA-Mediated Immune Checkpoint Modulation in Triple Negative Breast Cancer Mice Model

  2025cites this paper
• Advancements in vaccine development and therapeutic approaches for severe fever with Thrombocytopenia Syndrome

  2025cites this paper
• Lipid nanocarriers for RNA and DNA therapeutics: Next-generation delivery strategies in precision medicine

  2025cites this paper
• Discovery and development of COVID-19 vaccines and therapeutics: nonclinical perspectives.

  2024cites this paper
• Correlating Stability-Indicating Biochemical and Biophysical Characteristics with In Vitro Cell Potency in mRNA LNP Vaccine

  2024cites this paper
• Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models

  2024cites this paper
• Tailoring Biomaterials Ameliorate Inflammatory Bone Loss

  2024cites this paper
• Charge neutralized poly(β-amino ester) polyplex nanoparticles for delivery of self-amplifying RNA

  2024cites this paper
• Transmission-Blocking Vaccines against Schistosomiasis Japonica

  2024cites this paper
• The Antigenic Activity, Safety and Reactogenicity of Vaccines Created Using the Recombinant Strain Escherichia Coli

  2024cites this paper
• BIOTECHNOLOGY AND GENETIC ENGINEERING: CURRENT ADVANCEMENTS, EMERGING CHALLENGES, AND FUTURE HORIZONS IN MODERN SCIENCE

  2024cites this paper
• Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy

  2024cites this paper
• The development and technologies of RNA therapeutics.

  2024cites this paper
• Antibody Response after 3-Dose Booster against SARS-CoV-2 mRNA Vaccine in Kidney Transplant Recipients

  2024cites this paper
• Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape

  2024cites this paper
• Lipid Nanoparticle-Based Delivery System—A Competing Place for mRNA Vaccines

  2024cites this paper
• mRNA-based therapeutics: looking beyond COVID-19 vaccines.

  2024cites this paper
• Analisis Pengaruh Vaksin Covid-19 Terhadap Nilai HbA1c Pasien DM Tipe-2 Di Puskesmas: Studi Retrospektive

  2024cites this paper
• Towards a Safer Future: Enhancing Vaccine Development to Combat Animal Coronaviruses

  2024cites this paper
• A nucleoside-modified rabies mRNA vaccine induces long-lasting and comprehensive immune responses in mice and non-human primates.

  2024cites this paper
• The need for novel influenza vaccines in low- and middle-income countries: A narrative review

  2024cites this paper
• Integrating Interpretability in Machine Learning and Deep Neural Networks: A Novel Approach to Feature Importance and Outlier Detection in COVID-19 Symptomatology and Vaccine Efficacy

  2024cites this paper
• Research progress of mosquito-borne virus mRNA vaccines.

  2024cites this paper
• A review on immunization of DNA vaccine

  2024cites this paper
• Lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective

  2024cites this paper
• COVID-19 vaccines: current and future challenges

  2024cites this paper
• Post-COVID-19 Vaccination Meningitis and Meningoencephalitis: A Systematic Review of Case Series and Case Reports.

  2024cites this paper
• SARS-CoV2 mRNA vaccine intravenous administration induces myocarditis in chronic inflammation

  2024cites this paper
• Engineered protein destabilization reverses intrinsic immune evasion for candidate vaccine pan-strain KSHV and SARS-CoV-2 antigens

  2024cites this paper
• Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies

  2024influential citation
• Design and development of mRNA and self-amplifying mRNA vaccine nanoformulations.

  2024cites this paper
• Development of mRNA Lipid Nanoparticles: Targeting and Therapeutic Aspects

  2024cites this paper
• mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy

  2024cites this paper
• ADAMTS12 serves as a novel prognostic biomarker and promotes proliferation and invasion in gastric cancer

  2024cites this paper
• Recent research advances in the development of Dabie Banda virus vaccines

  2024cites this paper
• The epidemiological trends of 40 national notifiable infectious diseases in China: An analysis of national surveillance data from 2013 to 2022

  2024cites this paper
• Enhancing siRNA cancer therapy: Multifaceted strategies with lipid and polymer-based carrier systems.

  2024cites this paper
• Plasma EV-miRNAs as Potential Biomarkers of COVID-19 Vaccine Immune Response in Cancer Patients

  2024cites this paper
• Advances in the study of LNPs for mRNA delivery and clinical applications

  2024cites this paper
• Potential use of CRISPR/Cas13 system for vaccine development against various RNA-viral infections

  2024cites this paper
• Navigating Fish Immunity: Focus on Mucosal Immunity and the Evolving Landscape of Mucosal Vaccines

  2024cites this paper
• Learning from the COVID-19 pandemic: A systematic review of mathematical vaccine prioritization models

  2024cites this paper
• Transforming Aquaculture through Vaccination: A Review on Recent Developments and Milestones

  2024cites this paper
• Optimizing hybrid neural networks for precise COVID-19 mRNA vaccine degradation prediction

  2024cites this paper
• Advances in Nucleic Acid Universal Influenza Vaccines

  2024cites this paper
• Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice

  2024cites this paper
• CodonBERT large language model for mRNA vaccines

  2024cites this paper
• Disease X and COVID-19: turning lessons from India and the world into policy recommendations

  2024cites this paper
• mRNA vaccines against infectious diseases and future direction.

  2024cites this paper
• Rational Design of Polymeric mRNA Delivery Vectors to Achieve Excellent Room-Temperature Storage Stability and Delivery Efficiency

  2024cites this paper
• Adverse Cardiovascular Effects of COVID-19 Vaccination: A Systematic Review

  2024cites this paper
• Recent progress in macromolecules: From current therapeutic strategies to theranostic applications

  2024cites this paper